Tryptophan hydroxylase of the central nervous system: effect of intraventricular 5,6- and 5,7-dihydroxytryptamine.
D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000818:Animals; D001369:Axons / Q000378:metabolism; D001921:Brain / Q000201:enzymology* / Q000378:metabolism; D001933:Brain Stem / Q000201:enzymology; D002552:Cerebral Ventricles; D003067:Coenzymes / Q000378:metabolism; D003513:Cycloheximide / Q000494:pharmacology; D003864:Depression, Chemical; D004355:Drug Stability; D005246:Feedback; D007267:Injections; D007700:Kinetics; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D009411:Nerve Endings / Q000201:enzymology; D009474:Neurons / Q000378:metabolism; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000096:biosynthesis; D013552:Swine; D014363:Tryptamines / Q000008:administration & dosage / Q000494:pharmacology*; D014365:Tryptophan Hydroxylase / Q000037:antagonists & inhibitors / Q000302:isolation & purification / Q000378:metabolism
D003067:Coenzymes; D014363:Tryptamines; D012701:Serotonin; D012110:Reserpine; D003513:Cycloheximide; D006899:Mixed Function Oxygenases; D014365:Tryptophan Hydroxylase